The United States Patent and Trademark Office (USPTO) has issued patent US12582308B2 to Topcon Corporation. This patent grants exclusive rights for an "Ophthalmic apparatus and method of controlling the same." The invention utilizes optical coherence tomography (OCT) to capture tilt information of the anterior eye segment, which is then used by a controller to adjust a fixation target presented to the subject. The patent was filed on October 11, 2021, and granted on March 24, 2026, with 17 claims.

This patent grant establishes intellectual property protection for Topcon Corporation's technology in the field of ophthalmic diagnostics and treatment. While not imposing direct regulatory obligations on other entities, it signifies a new innovation that competitors and collaborators in the medical device and healthcare technology sectors should be aware of. Companies involved in developing or utilizing OCT imaging, ophthalmic diagnostic equipment, or eye-tracking systems should review the patent's claims to ensure their own products or processes do not infringe upon this granted IP. No immediate compliance actions are required for entities outside of Topcon Corporation, but awareness is crucial for strategic planning and potential licensing discussions.